Results 111 to 120 of about 1,235,569 (268)
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo +8 more
wiley +1 more source
A few splitting theorems for rank two vector bundles on P^4
Paolo Valabrega
openalex +2 more sources
Transformer-Based Multi-modal Proposal and Re-Rank for Wikipedia Image-Caption Matching [PDF]
Nicola Messina +3 more
openalex +1 more source
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine +10 more
wiley +1 more source
The Interface between Instrument and Observer
S. C. Bottomley
doaj +1 more source
Sparse Unmixing of Hyperspectral Data by Exploiting Joint-Sparsity and Rank-Deficiency
Fanqiang Kong, Chending Bian
openalex +2 more sources
A Stochastic Sequential Quadratic Optimization Algorithm for Nonlinear Equality Constrained Optimization with Rank-Deficient Jacobians [PDF]
Albert S. Berahas +3 more
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Frequency–rank correlations of rhodopsin mutations with tuned hydropathic roughness based on self-organized criticality [PDF]
J. C. Phillips
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source

